Bracketing approach for multiple strenght product EMA [Regulatives / Guidelines]

posted by jag009  – NJ, 2021-07-06 19:19 (110 d 15:11 ago) – Posting: # 22462
Views: 545

Hi all,

For drug product which have multiple strengths (lets say 3), my thinking is to run a BE study comparing highest and lowest strength, and present dissolution similarities between the three strengths + a formulation composition table showing that the formulations are proportional.

Question: What if the product release > 85% within 15 mins? If so then one can't use dissolution to demonstrate similarity.

The product is BCS class 2.

Thx

J

Complete thread:

Activity
 Admin contact
21,756 posts in 4,548 threads, 1,544 registered users;
online 7 (1 registered, 6 guests [including 3 identified bots]).
Forum time: Monday 10:30 CEST (Europe/Vienna)

The plural of anecdote is data.    Raymond Wolfinger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5